Ambu A/S Stock Forecast for 2023 - 2025 - 2030
Updated on 04/20/2024
Ambu A/S Stock Forecast and Price Target
The average target price for Ambu A/S's stock set by renowned analysts in recent months is kr115.00, representing a potential upside of approximately 5.22% from its last closing price if met by 2025. This estimation is based on a high estimate of kr130.00 and a low estimate of kr52.00. If you're considering investing in AMBU B stock, it's essential to look at its competitors, too.
5.22% Upside
Ambu A/S Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Ambu A/S's Price has decreased from kr113.48 to kr0.00 – a 100.00% drop. In the next year, analysts believe that Fair Value will reach kr154.43 – an increase of 100.00%. For the next eight years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ABT Stock Forecast | Abbott Laboratories | Outperform |
9
|
$107.28 | Buy/Sell | $118.92 | 18.38% |
| SYK Stock Forecast | Stryker Corp | Outperform |
10
|
$325.43 | Buy/Sell | $353.16 | 12.62% |
| MDT Stock Forecast | Medtronic | Outperform |
11
|
$79.48 | Buy/Sell | $92.47 | 20.16% |
| BSX Stock Forecast | Boston Scientific | Outperform |
11
|
$67.33 | Buy/Sell | $70.14 | 8.42% |
| BAX Stock Forecast | Baxter International Inc | Outperform |
17
|
$39.47 | Buy/Sell | $44.86 | 14.01% |
Ambu A/S Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Ambu A/S's Revenue has grown, rising from kr3.57B to kr4.78B – a growth of 33.87%. In the next year, analysts believe that Revenue will reach kr5.24B – an increase of 9.69%. For the next seven years, the forecast is for Revenue to grow by 49.47%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| STE Stock Forecast | STERIS | Outperform |
13
|
$199.51 | Buy/Sell | $238.33 | 19.30% |
| TFX Stock Forecast | Teleflex Inc | Hold |
13
|
$206.56 | Buy/Sell | $263.46 | 28.29% |
| CNMD Stock Forecast | CONMED | Outperform |
16
|
$72.64 | Buy/Sell | $123.38 | 47.99% |
.jpg)
Ambu A/S Dividend per Share Forecast for 2023 - 2025 - 2030
In the last year, Ambu A/S's Dividend per Share has decreased by 0.00%, going from kr0.29 to kr0.29. In the next year, analysts believe that Dividend per Share will reach kr0.33 – an increase of 13.79%. For the next seven years, experts predict that Ambu A/S's Dividend per Share will grow at a rate of 75.01%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| PCRX Stock Forecast | Pacira BioSciences | Outperform |
16
|
$26.25 | Buy/Sell | $47.90 | 71.43% |
| AVNS Stock Forecast | Avanos Medical | Hold |
11
|
$18.71 | Buy/Sell | $23.50 | 25.60% |
| MOTS Stock Forecast | Motus GI Holdings | - |
-7
|
$0.08 | Buy/Sell | $8.30 | -100.00% |
Ambu A/S EBITDA Forecast for 2023 - 2025 - 2030
Ambu A/S's EBITDA has decreased by 17.28% In the last three years, from kr515.00M to kr426.00M. For the next year, analysts predict that EBITDA will reach kr856.02M – an increase of 100.94%. Over the next seven years, experts believe that Ambu A/S's EBITDA will grow at a rate of 453.53%.
Ambu A/S EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Ambu A/S's EBIT has decreased from kr428.00M to kr302.00M – a 29.44% drop! In the next year, analysts predict that EBIT will jump to kr491.34M – up 62.70% from the current level. Looking ahead to seven years, experts forecast that EBIT will grow by 453.11%.
Ambu A/S EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Ambu A/S's EPS has decreased from kr0.97 to kr0.00 – a 100.00% drop. In the next year, analysts believe that EPS will reach kr1.32 – an increase of 100.00%. For the next eight years, the forecast is for EPS to grow by 100.00%.
.jpg)